Introduction
Beijing Luzhu Biotechnology Co Ltd is a China-based company primarily engaged in the research, development and production of vaccines and therapeutic biologics. The Company is also engaged in the development of innovative human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Company's products include clinical-stage product candidates and pre-clinical-stage product candidates. The core product LZ901 is mainly used to prevent shingles caused by the varicella-zoster virus in adults aged 50 years and above. The Company mainly conducts its businesses in the domestic market.